Virtu Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-34,545
| Closed | -$7K | – | 2174 |
|
|
2023
Q2 | $7K | Sell |
34,545
-141,984
| -80% | -$24.7K | ﹤0.01% | 1384 |
|
|
2023
Q1 | $28K | Buy |
176,529
+109,992
| +165% | +$48.8K | ﹤0.01% | 1184 |
|
|
2022
Q4 | $37K | Buy |
+66,537
| New | +$56.6K | ﹤0.01% | 1140 |
|
|
2022
Q3 | – | Sell |
-16,636
| Closed | -$11K | – | 2419 |
|
|
2022
Q2 | $11K | Buy |
+16,636
| New | +$12.8K | ﹤0.01% | 1422 |
|
|
2022
Q1 | – | Sell |
-82,316
| Closed | -$185K | – | 2286 |
|
|
2021
Q4 | $185K | Buy |
82,316
+47,150
| +134% | +$118K | 0.02% | 865 |
|
|
2021
Q3 | $120K | Sell |
35,166
-80,146
| -70% | -$247K | 0.01% | 1081 |
|
|
2021
Q2 | $345K | Buy |
115,312
+52,328
| +83% | +$166K | 0.03% | 647 |
|
|
2021
Q1 | $203K | Buy |
+62,984
| New | +$210K | 0.01% | 1084 |
|
|
2020
Q3 | – | Sell |
-12,283
| Closed | -$11K | – | 1660 |
|
|
2020
Q2 | $11K | Buy |
+12,283
| New | +$11.7K | ﹤0.01% | 1181 |
|
|
2019
Q4 | $27K | Buy |
+27,796
| New | +$30.5K | ﹤0.01% | 1282 |
|
|
2019
Q2 | – | Sell |
-10,791
| Closed | -$20K | – | 1981 |
|
|
2019
Q1 | $20K | Sell |
10,791
-16,915
| -61% | -$24.7K | ﹤0.01% | 1290 |
|
|
2018
Q4 | $33K | Buy |
+27,706
| New | +$49.8K | ﹤0.01% | 1322 |
|
|
2018
Q2 | – | Sell |
-70,854
| Closed | -$149K | – | 2634 |
|
|
2018
Q1 | $149K | Buy |
+70,854
| New | +$152K | 0.01% | 1470 |
|
|
2017
Q4 | – | Sell |
-10,339
| Closed | -$14K | – | 3173 |
|
|
2017
Q3 | $14K | Buy |
+10,339
| New | +$12.8K | ﹤0.01% | 2391 |
|
Other funds holding INFI
Virtu Financial's INFI Position: Q3 2023 in Review
Virtu Financial sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 34,545 shares — an estimated $7K sold.
Virtu Financial first reported a position in INFI in Q3 2017 and held it in 14 quarters. The position peaked at $345K in Q2 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Virtu Financial reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Virtu Financial sold 34,545 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $7K.
- Virtu Financial first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2017 and held it in 14 quarters.
- Virtu Financial's Infinity Pharmaceuticals, Inc. position peaked at $345K in Q2 2021.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.